The recent discovery of an association between body composition, energy intake and the fat mass and obesity-associated (FTO) gene represents a promising new therapeutic target in obesity prevention. In a well, pre-established large animal model, we investigated the regulation of FTO gene expression under conditions either leading to obesity or increased risk of obesity related disorders: i) a sedentary 'Western' lifestyle and ii) prenatal exposure to nutrient restriction. Pregnant sheep were either fed to fully meet their nutritional requirements throughout gestation or 50% of this amount from early-to-mid gestation. Following weaning, offspring were either made obese through exposure to a sedentary obesogenic environment or remained lean. A significant positive relationship between placental FTO gene expression and fetal weight was found at 110 days gestation. In both the newborn and adult offspring, the hypothalamus was the major site of FTO gene expression. Hypothalamic FTO gene expression was upregulated by obesity and was further increased by prenatal nutrient restriction. Importantly, we found a strong negative relationship between the hypothalamic FTO gene expression and food intake in lean animals only that may imply FTO as a novel controller of energy intake. In contrast, FTO gene expression in the heart was downregulated in obese offspring born to nutrient restricted mothers. In addition, FTO gene expression was unaffected by obesity or prenatal diet in insulin-dependent tissues, where it changed with age possibly reflecting adaptations in cellular energetic activity. These findings extend information gained from human epidemiology and provide new insights into the regulation of in vivo energy metabolism to prevent obesity.
Introduction
The global incidence of obesity is currently exhibiting a dramatic increase worldwide in children, adolescents, and adults. Obesity (i.e. body mass index (BMI) O30 kg/m 2 ) is a well-defined pathological state due to excessive accumulation of lipids in white adipose tissue; however, its main causes remain an area of intense debate (Blakemore & Froguel 2008 , Dina 2008 . Very recently, genomewide association studies reproducibly found genetic variants in the fat mass and obesity-associated (FTO) gene to be strongly associated with the risk of obesity (Dina et al. 2007 , Price et al. 2008 , Tan et al. 2008 , Villalobos-Comparan et al. 2008 They consistently found that FTO single nucleotide polymorphisms (SNP) between populations, especially for the SNP rs9939609 carriers, are related to substantial rises in BMI, body weight, and/or waist circumference ; although others have suggested it may only account for 1% of the heritability of obesity in humans (Dina 2008) .
The main function of the product of the FTO gene is yet to be discovered. This gene is widely expressed in a range of human and animal (Gerken et al. 2007 ) tissues, with its expression being highest in the brain including the hypothalamic arcuate nucleus, one of the main appetite regulating centers (Gerken et al. 2007 ). In mice (Gerken et al. 2007 ) and rats (Fredriksson et al. 2005) , hypothalamic Fto mRNA abundance is modulated by nutritional status in a species-dependent manner. In mice, starvation downregulates Fto mRNA transcription (Gerken et al. 2007) , whereas in rats the opposite effect is seen (Fredriksson et al. 2005) . Although these results contradict each other, they, together with human data, show an association between energy intake and FTO polymorphisms (Teng et al. 2002 , Wardle et al. 2008 , suggesting that the product of the FTO gene could be involved in energy balance regulation. In addition, the FTO gene is ubiquitously expressed in all peripheral tissues tested to date. This includes some of the key tissues or organs involved in the control of energy metabolism and cardiovascular function (i.e. liver, adipose tissue, skeletal muscle, heart, kidney, and pancreas; Gerken et al. 2007 , Stratigopoulos et al. 2008 , Wahlen et al. 2008 . The extent to which alterations of FTO regulation in these organs can be involved in obesity and obesity-related disorders remain unknown. Interestingly, adipocyte FTO expression is upregulated with human obesity ) and FTO SNP allelic distribution correlates with some of the common features of obesity and insulin resistance syndrome, i.e. raised plasma leptin, adiponectin, C reactive protein (Do et al. 2008 , Fisher et al. 2009 ). Finally, adipocyte FTO has also been suggested to play a role in the regulation of lipolysis (Do et al. 2008 , Shoulders 2008 .
The FTO gene could thus have a primary role in the occurrence of obesity. To assess its biological role, tissuespecific gene expression needs to be studied within the context of exposure to obesogenic environments. In conjunction with energy imbalance and genetic predisposition, obesity, or risk of obesity-related disorders, can also originate from the prenatal energetic environment. Indeed, the nutritional status, during critical periods, in which the fetus grows and develops, is an important factor in determining body weight and energy homeostasis (McMillen et al. 2004 . The extent to which the FTO gene is developmentally regulated and may be reset by the in utero environment is yet to be determined and was thus the primary aim of the present study. We therefore examined FTO mRNA expression in a range of tissues sampled from mothers and offspring during critical stages of development, i.e. in the i) placenta at mid-gestation, ii) neonate at 7 days of age, and iii) lean and obese adults at 1 year. This analysis was undertaken in tissue samples taken from mothers fed to requirements and those nutrient restricted (NR) from early-to-mid gestation; a period we have previously established to have a pronounced impact on the control of food intake and organ endocrine sensitivity either in the neonate (Whorwood et al. 2001) or in the adult following obesity , Sharkey et al. 2009 ).
Results
Study 1: placental expression of FTO Maternal nutrient restriction during critical periods of gestation can affect placental function and metabolism (Gnanalingham et al. 2007) . That said, in Scottish Blackface sheep, we found no significant effects of maternal nutrient restriction from 30 to 65 days gestation on either placental (Control (C): (nZ4): 630G161; NR: (nZ5): 636G94 g) or fetal body (C: 2.08G0.12; NR: 2.22G0.20 kg) weight at 110 days gestation. Interestingly, FTO mRNA transcription was highly abundant in placental tissue as compared to the other tissues characterized in the present study (Fig. 1) . Its expression was, however, unaffected by maternal nutrient intake during early-to-mid gestation (C: (nZ4): 1.0G0.3; NR: (nZ5): 1.5G0.4-fold change; arbitrary units). Nevertheless, we observed a positive relationship between placental FTO mRNA abundance and fetal weight as determined at 110 days gestation (Fig. 2) .
Study 2: influence of obesity and maternal nutrient restriction on FTO gene expression Maternal nutrient restriction by 50% from early-to-mid gestation had no effect on either birth or bodyweight or organ mass up to 7 days of age (Table 1) . As expected, post-weaning exposure to an obesogenic environment Figure 1 Comparison of FTO gene expression in all major tissue types in offspring born to control fed animals sampled as either (A) neonates (i.e. 7 days of age), together with the 110 day placenta and (B) young adults (i.e. 1 year of age). Values represent meansGS.E.M.; different superscript within each age group indicates significant differences between tissues (a vs b P!0.05; a vs c P!0.001).
markedly increased total body weight as well as fat mass at 1 year of age ( Table 1 ). The only organ that did not increase in size in proportion to the rise in total body mass was the heart. The prenatal environment had no influences on body mass and composition following obesity in NR obese (NRO) offspring.
We have previously described in more detail , Sharkey et al. 2009 ) that maternal nutrient restriction during early-to-mid-gestation influenced the outcomes of juvenile obesity. Critically, concerning the control of food intake, NRO offspring ate substantially less than obese offspring born to control mothers (obese (O): 15.9G0.5 MJ/24 h; NRO: 12.1G0.8 MJ/24 h; P!0.05), an adaptation driven by the hypothalamus through upregulation of the energy sensing pathways ).
FTO gene expression and distribution
The FTO gene is a well-conserved gene between animal species (Fredriksson et al. 2005) . Sequence data obtained for the FTO amplicon confirmed sequence homology to ovine FTO and to the FTO gene across species including humans (Fig. 3) suggesting comparative functionality. As in humans , the ovine FTO gene was expressed in a wide variety of tissues, with maximal abundance in the hypothalamus, followed by skeletal muscle, and placenta. A majority of the other tissues analyzed showed an approximate tenfold lower expression when compared to the hypothalamus ( Fig. 1A and B) . Importantly, this hypothalamic predominance was observed both at birth and in adulthood. In addition, the lowest expression of FTO mRNA was measured in the kidney and pancreas.
Tissue-specific FTO gene expression Hypothalamus. Prenatal nutrient restriction was not found to alter FTO gene expression in the newborn. However, FTO mRNA abundance doubled between birth and 1 year of age (Fig. 4A) . FTO gene expression in the hypothalamus was amplified with obesity (P!0.05) and, importantly, prenatal exposure to maternal nutrient restriction in early pregnancy resulted in a further upregulation in FTO mRNA transcription induced by obesity (P!0.01 against O animals). Finally, we observed a significant negative correlation between food intake and FTO gene expression in lean animals at one year of age (Fig. 4B) , a relationship lost with obesity.
Heart. No immediate effect of the prenatal diet on cardiac FTO gene expression was measured in the newborn. Nonetheless, in the 1-year-old NR offspring following obesity, cardiac FTO mRNA abundance was significantly downregulated compared to obese offspring born to control mothers ( 
Body weight (kg)
Individual tissues/organs
Individual tissues/organs PAT Kidneys Liver Heart Pancreas Pancreas. Pancreatic FTO gene expression was decreased with age (P!0.05). Interestingly, we measured a further reduction of its expression following obesity but no specific effect of the prenatal diet was seen (Table 2) .
Kidney. Similar to the pancreas, renal FTO gene expression was unaffected by the prenatal diet. However, obese animals exhibited a significant upregulation of FTO mRNA abundance (Table 2) .
Adipose tissues. FTO mRNA abundance was similar between fat depots at 1 year of age (e.g. in lean (nZ7) -perirenal: 1.0G0.12; pericardial: 1.33G0.35-fold change). Perirenal adipose tissue, the most abundant fat depot in our model, expressed more FTO mRNA at 7 days compared to 1 year of age (P!0.05). Obesity tended (PZ0.08) to increase adipose tissue FTO mRNA abundance an adaptation that was independent of the maternal nutritional environment (lean (L)Z0.7G0.1; OZ1.1G0.2; NROZ1.0G0.2).
Liver and skeletal muscle. There was no effect of prenatal diet and the age-related changes between 7 days and 1 year of age in FTO mRNA abundance (i.e. decrease in liver and an increase in skeletal muscle) were unaffected neither by obesity nor maternal nutrition (Table 2) in both tissue types.
Discussion
Within the past year exciting new evidence from genome-wide association studies reproducibly highlighted the FTO SNP allelic distribution as a predictive factor for obesity in various human populations (Dina et al. 2007 , Al-Attar et al. 2008 , Freathy et al. 2008 , Hotta et al. 2008 , Hubacek et al. 2008 , Willers et al. 2008 ). The mechanisms underlying the physiological relationship between FTO allelic variations and alterations of body weight homeostasis are yet to be elucidated. Tissue-specific genetic regulation of FTO transcription together with obesity development represents a first step to assess its biological functions. Our study thus explored, for the first time, the regulation of the FTO gene transcription in experimental environments known to promote obesity-related metabolic disorders. We have thus demonstrated obesity-related alterations of FTO together with the novel finding that FTO gene expression is developmentally regulated in the hypothalamus and in the heart, a response dependent on the prenatal nutritional environment.
Obesity-related alterations
Overweight sheep offers an interesting alternative model to study the origins and consequences of human obesity (Sharkey et al. 2009 ) although it is recognized that the sheep is a ruminant and thus has a very different diet and digestive system to humans. Notwithstanding this point this model of environmental induction of obesity, excessive body fat deposition resulted in similar physiological and metabolic complications to those seen in human obesity including glucose intolerance, hyperinsulinemia, hyperleptinemia, and leptin resistance together with raised blood pressure , Sharkey et al. 2009 ). In our model, one of the main obesity-related changes in FTO gene expression was an upregulation in the entire hypothalamus. In mice, FTO is predominantly expressed in the arcuate nucleus of the hypothalamus (Gerken et al. 2007 ), a key neuronal centre for food intake control (Masuzaki et al. 2001 ) and therefore suggest a role for FTO in the control of food intake. It thus raises the question as to whether the alteration of hypothalamic FTO gene expression that we found partly characterized the dysregulation of the control of food intake related to obesity ). Intriguingly, we found hypothalamic FTO mRNA abundance in lean animals to be negatively related to daily energy intake. This relationship was lost with obesity but, the further elevation of FTO expression in the offspring born to NR mothers was associated with a significant reduction of food intake. In addition, together with findings from both human and animal studies, our study further supports a role for FTO in the control of food intake that appears to be reset following obesity. In rodents, hypothalamic FTO gene expression is associated with energy intake (Fredriksson et al. 2005 , Gerken et al. 2007 , while in humans, allelic distributions of FTO SNPs are similarly related to alterations of energy intake in childhood , Wardle et al. 2009 . It thus appears possible that the FTO SNP rs9939609 promotes substantial perturbations in energy balance that ultimately leads to obesity.
Results from human studies further indicate that FTO gene expression in adipocytes can be upregulated in obesity (Kloting et al. 2008 ), an adaptation dependent on duration and severity. In our ovine model, we found a trend for a similar response in perirenal adipose tissue, suggesting that with an extended period of obesity the same adaptation would occur. We also observed for the first time that adolescent-onset obesity was associated with local alterations of FTO gene expression in the kidney and pancreas. The extent to which such changes in FTO gene regulation are a cause or consequence of obesity and thus has a role in the etiology of the classical perturbations observed during the metabolic syndrome remains to be established. Significant differences with age between control animals (i.e. C; 7 days versus L; 1 year of age) indicated by *; *P!0.05. Significant differences between L and O groups at 1 year of age indicated by †; † P!0.05. PAT, perirenal adipose tissue; SM, skeletal muscle. . FTO gene expression is upregulated in the hypothalamus following a combination of in utero exposure to nutrient restriction followed by juvenile obesity. In the present study, we also found FTO mRNA to be highly expressed in the placenta and to be positively related to fetal weight. This strong relationship suggests that FTO is one factor involved in regulating fetal energy supply a proposal that is supported by the observation in newborn humans in which, the rs9939609 SNP in FTO is positively associated with specific metabolic parameters including fat mass and visfatin concentration (Lopez-Bermejo et al. 2008). We did not, however, find any alterations in FTO mRNA abundance in any of the neonatal tissues examined. Nonetheless, the developmental origins of adult health and diseases remain a complex physiological process. Cell-specific adaptations to changes in the fetal nutritional environment appear to be dependent not only on the in utero environment but also to a potential mismatch between the pre-and post-natal nutritional environments (Hanson & Gluckman 2008 , Vickers et al. 2008 . Our results, therefore, suggest that adolescent onset of obesity is necessary to induce the phenotypic responses programmed by maternal nutrient restriction. However, future work will need to incorporate lean offspring born to NR mothers in order to fully confirm our hypothesis. Nevertheless, previous works from our group have already seen no differences in the control of food intake or metabolism in these offspring when they remain lean . Two of our main findings are that FTO gene expression in NR offspring is reset in the hypothalamus and heart following adolescent-onset obesity. The period of early-to-mid gestation in the sheep can be compared to the first trimester of human pregnancy and represents a period of maximal placental growth that coincides with critical periods of heart morphogenesis and neuronal network remodeling, including hypothalamic networks. Maternal nutrient restriction was therefore specifically chosen in order to establish the long-term adaptations upon the functions of these organs following obesity. The main characteristics of our particular model is a reduction of food intake following obesity ), without substantial weight loss, and intra-cardiac accumulation of triglycerides ) in conjunction with marked adipose tissue-specific stress and inflammation responses (Sharkey et al. 2009 ). Taken together, these adaptations suggest an amplified response to obesity in offspring born to NR mothers. Interestingly, FTO was one of the few genetic factors, co-expressed together with modulators of energy sensing e.g. PRKA (AMPK), ACACA (ACC-alpha), and PPARGC1A (PGC-1 alpha), for which hypothalamic gene expression in the adult is promoted by maternal nutrient restriction ). We thus suggest that during this critical developmental window, early maternal nutrient restriction induced long-term adaptation towards hypothalamic and cardiac energy sensing. These findings could now enable us to gain a better understanding of the developmental origins of obesity and metabolic diseases. We therefore raise the question as to whether the developmentally-induced modulations of FTO expression are related to a consistent resetting of energy sensing. Using bioinformatic sequence homology analysis, the FTO gene has been shown to encode a 2-oxoglutarate-dependent DNA demethylase (Gerken et al. 2007 , Sanchez-Pulido & Andrade-Navarro 2007 . This indicates a novel molecular link between energy generated via the Krebs cycle through modulation of intra-cytoplasmic concentrations of 2-oxoglutarate concentration, and gene transcription via DNA demethylation. It could therefore be very likely that cell metabolism may regulate FTO gene expression and this clearly requires further investigation. Tissuespecific biological functions of the FTO-related peptide remain to be fully established. However, a recently developed FTO-deficient mouse (Fischer et al. 2009) provides new insights into the biological systems regulated by FTO. Systemic depletion of the FTO gene resulted in major growth impairment of white, but not brown, adipose tissue leading to lipodystrophy and resistance against obesity. These mice were also hyperphagic and exhibited substantial alterations in energy expenditure leading to raised heat production. The extent to which similar roles are present in large mammals remains to be established but we clearly observed that the early nutritional environment can have a modulating role.
An improved understanding of the primary mechanisms regulating body weight homeostasis and energy balance is critical to current public health concerns with respect to obesity. In this regard, we have found that regulation of the FTO gene undergoes profound developmental adaptations that are dependent on maternal nutritional status, age, and fat mass. It is highly expressed in the hypothalamus and represents a new molecule involved in the control of food intake. Furthermore, FTO gene expression is modified by obesity both in the hypothalamus and the heart following exposure to prenatal NR coincident with early organogenesis. As to whether the specific alterations of FTO gene expressions we observed, following NR, either contributes directly or are a compensatory factor towards obesity development requires further investigation. In addition to fetal programming of FTO gene expression, we found obesity-dependent effects on FTO gene expression in the hypothalamus, adipose tissue, kidney, and pancreas that could represent an important adaptation in obesity development and obesity-related diseases such as hypertension and type II diabetes. There is a clear need for further research efforts to be prioritized in this area. Taken together, our unique findings lends further support to previous small animal studies (Fredriksson et al. 2005 , Gerken et al. 2007 , Fischer et al. 2009 ) for the FTO gene to be classified as a novel controller of food intake and as a cellular energy sensor that is developmentally and nutritionally regulated. Importantly, we confirm some strong links between FTO and obesity, in a large animal model, that may promote the discovery of new pathways for targeting therapeutic strategies designed to prevent obesity and its associated metabolic complications and social and financial implications.
Materials and Methods

Animals, diets and experimental design
All procedures were performed in accordance with the UK Animals (Scientific Procedures) Act (1986) and approved by the local ethics committee of the University of Nottingham and Aberdeen. The present paper utilized tissue samples obtained from two independent studies previously performed which were designed to analyze the nutritional regulation of placental development and the fetal programming of obesity and related disorders as summarized in Fig. 6 . These two independent studies thus provide an excellent opportunity to answer our hypothesis but cannot be interpreted as a single study.
Study 1: influence of nutrient restriction during the period of maximal placenta growth on placental FTO gene Nine singleton-bearing Scottish Blackface sheep were either fed a control diet (nZ4) or a 50% of this amount i.e. NR (nZ5) during the period of maximal placenta growth in sheep i.e. between 30 and 65 days of gestation, as previously described (Brennan et al. 2005) . At 110 days of gestation, all mothers were euthanized, the fetus weighed, and placentomes randomly sampled for molecular analysis.
Study 2: influence of maternal nutrient restriction followed by adolescent-onset obesity on FTO gene expression in resultant offspring FTO gene expression was assessed in a range of tissue samples collected from animals previously used to study the early nutritional programming of food-intake regulation . Briefly, at day 30 of gestation, 25 twin-bearing Welsh Mountain sheep were randomly allocated into two groups to receive either a control (7 MJ/day: C: nZ15) or NR (50% of C, nZ10) diet until day 80 of gestation ( Fig. 6) . Thereafter, all sheep were fed 100% of their calculated metabolisable energy requirements up to term (12-13 MJ/day near term; Agricultural and Food Research Council 1993) . All offspring were delivered spontaneously at term (w147 days). The female to male ratio was (1:1) in the control and (2:1) in the NR group. Seven control offspring and 12 NR offspring were tissue sampled at 7 days of age. For ethical considerations, in order to reduce the number of mothers entered into the study, eight of the newborn control twins (twin 1) were allocated to a separate independent study. The remaining offspring (C: nZ15; NR: nZ8) were reared by their mothers until weaning (w10 weeks of age). During lactation, all mothers were fed a diet of hay ad libitum, together with a fixed amount of concentrate pellets, sufficient to fully meet their own metabolizable requirements, as well as those required to maintain lactation. From weaning to 12 months of age, the O (nZ8) and NR (nZ8) offspring were exposed to an 'obesogenic' environment: i.e. group housed in a barn at a stocking rate of 17 animals per 50 m 2 with ad libitum access to hay and concentrate pellets, as previously described ). The remaining control offspring (nZ7) were reared in a nonobesogenic standard 'free-living' environment: i.e. put out in the pasture at a stocking rate of 17 animals per 3000 m 2 with free-grazing allowance and a fixed amount of concentrate pellets (400 g/day). Neonatal offspring sampled at 7 days of age were thus grouped according to the maternal nutritional environment: i.e. control or NR. The remaining post weaning 'free-living' offspring were defined as L (nZ7). Offspring raised in the obesogenic environment were redefined as O (nZ8) or NRO (nZ8). Just prior to dissection, at 12 months of age, adult offspring were individually penned and their daily energy intake recorded (i.e. food offered minus food refusal over 24 h) in order to assess some aspects of food intake regulation ).
Post-mortem analysis
Study 1
At dissection (110 day gestation), individual placentomes were dissected and weighed in order to calculate total placental mass for each fetus. Fetal body weight was also recorded. Representative A type placentomes (that constitute w80% of all placentomes at this stage of gestation) were randomly sampled, snap frozen in liquid nitrogen and stored at K80 8C. Approximately 100 mg of maternal caruncular placentome were dissected for RNA extraction.
Study 2
All offspring were tissue sampled in the morning between 0900 and 1100 h. The 1-year-old offspring were euthanized as previously described after an overnight fast . Seven day old offspring could not be subjected to a similar period of food withdrawal as this would have meant prolonged physical separation from their mothers and, as such, would have been unethical. Following euthanasia, the whole brain was immediately recovered and the entire hypothalamus dissected, snap frozen in liquid nitrogen and stored at K80 8C as previously described ). In addition, the perirenal adipose tissue depot, that is the most abundant depot in young sheep (Alexander & Bell 1975) , heart, kidney, liver, pancreas, and skeletal muscle (Longissimus dorsi) were rapidly sampled, snap frozen in liquid nitrogen and immediately stored at K80 8C until molecular analyses.
Determination of FTO expression and mRNA abundance
Total RNA was extracted from all tissues using Qiazol lysis reagent and RNeasy extraction kit (Qiagen Ltd) which included a DNAse I digestion (RNase-Free DNase Set, Qiagen Ltd). In the case of adipose tissue the lipid was first discarded (Sebert et al. 2005) . One microgram of total RNA was then reverse transcribed into cDNA (Superscript II RT, Invitrogen Ltd). FTO gene expression was determined using the entire hypothalamus as has previously been used to study the regulation of food intake in rats (Teske et al. 2006 , Sahu 2008 , mice (Sellayah et al. 2008) , and sheep (Warnes et al. 1998 ). It is recognized that the hypothalamus is not a homogeneous entity but includes many nuclei that may exhibit differential regulation of FTO gene expression (Gerken et al. 2007 ). The advantage of using the entire hypothalamus is that it enabled us to obtain quantitative information with regard to the effect of age, maternal diet, obesity, and to compare FTO gene expression between tissues.
The FTO primers utilized were; forward: 5 0 -ACA CAT GGC TTC CCT ACC TG-3 0 , reverse: 5 0 -GAG GAT GCG AGA GAC TGG AG-3 0 were designed from the published ovine FTO sequence (gene bank accession number: EU972419). The PCR product was gel extracted (QIAquick Gel Extraction Kit, Qiagen Ltd) and sequenced (Fig. 6 ) in order to confirm amplicon specificity and to generate a standard curve (tenfold serial dilutions) for real-time PCR analysis.
Gene expression was determined by a real-time PCR thermocycler (Quantica, Techne Incorporated, Barloword Scientific Ltd, Stone, UK) using the Quantitect SYBR greenbased PCR kit (Qiagen Ltd; Mostyn et al. 2006) . 18S rRNA; (forward: 5 0 -GAT GCG GCG GCG TTA TTC C-3 0 , reverse: 5 0 -CTC CTG GTG GTG CCC TTC C-3 0 ) and Acidic Ribosomal Protein P0 (RPLO ) (forward: 5 0 -AG CAA GTG GGA AGG TGT AAT-3 0 , reverse: CCC ATT CTA TCA TCA ACG GGT A-3 0 ) were used as housekeeping genes and results calculated using the 2 KDC t method (Livak & Schmittgen 2001) . We also assessed the suitability of a number of other house keeping genes including cyclophilin although only RPLO was shown not to be influenced by the in vivo experimental conditions. There was no difference in any of the results obtained when using either 18S or RPLO therefore we have only presented results when using 18S. To enable inter-tissue comparisons, the mRNA abundance measured in the 7-day-old hypothalami was chosen as a reference to enable a direct comparison between tissues; this was also the case for the 1-year-old hypothalamus samples. However, to analyze intra-tissue-specific modifications, the mean mRNA abundance of values obtained in the control group at 7 days of age for the related tissue was used and therefore, acted as an internal reference for each separate tissue being examined.
Statistical analyses
Statistical analyses were performed using SPSS v14.0 for Windows (SPSS Inc., Chicago, IL, USA). To assess the data for normality, we performed a Kolmogorov-Smirnov test. Data were all found to be normally distributed and therefore analyzed using parametric tests as follow: Study 1: unpaired Student's t-tests were used to compare FTO expression between groups. Study 2: 1) tissue comparisons in the 7-day-old and separately in the 1-year-old offspring were made by one-way ANOVA with Bonferroni post-hoc tests. 2) In order to assess the effects of age (i.e. C (7-day-old) versus L (1-year-old)) paired Student's t-test (comparison of heterozygote twins) were used, 3) both the effect of maternal nutrient restriction (i.e. 7-day-old C versus NR and 1-year-old O versus NRO animals) and of postnatal obesity (L versus O) we used an unpaired Student's t-test. Data are presented as means GS.E.M., with a P value !0.05 indicating statistically significant differences between groups.
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